Indicators
Indicators
Value
Direction
MACD(12,26,9)
3.590
Neutral
RSI(14)
37.952
Neutral
STOCH(KDJ)(9,3,3)
47.287
Sell
ATR(14)
8.734
Low Volatility
CCI(14)
-29.524
Neutral
Williams %R
40.787
Buy
TRIX(12,20)
-0.585
Sell
StochRSI(14)
36.099
Buy
Elevance Health Inc
ELV290.330USD
+1.090+0.38%
Close 03/24, 16:00（ET）Quotes delayed by 15 min
96.33BMarket Cap
11.49P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Elevance Health Inc
Currency: USD Updated: 2026-03-24Key Insights
Elevance Health Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is significant.Its valuation is considered fairly valued, ranking 30 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 385.02.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Elevance Health Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
44°C
Very Low
Very High
Negative-
Elevance Health Inc Highlights
StrengthsRisks
Elevance Health, Inc. is a health company. It operates as a health insurer in the United States. The Company operates through four segments: Health Benefits, CarelonRx, Carelon Services and Corporate & Other. The Health Benefits segment offers a comprehensive suite of health plans and services to its Individual, Employer Group risk-based, Employer Group fee-based, BlueCard, Medicare, Medicaid and Federal Employee Program (FEP) members. The Health Benefits segment also offers health products on a full-risk basis. The CarelonRx segment includes its pharmacy services business. CarelonRx markets and offers pharmacy services to its affiliated health plan customers, as well as to external customers outside of the health plans. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services by offering an array of healthcare-related services and capabilities to internal and external customers through its Carelon Health and Carelon Insights businesses.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 16.22% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 25.38%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 25.38%.
Undervalued
The company’s latest PE is 11.49, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 205.92M shares, increasing 0.01% quarter-over-quarter.
Held by Frank Sands
Star Investor Frank Sands holds 93.12K shares of this stock.
Analyst Rating
Based on
24
analysts
Buy
Current Rating
385.021
Target Price
+32.09%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-03-24The current financial score of Elevance Health Inc is 4.84, ranking 74 out of 75 in the Healthcare Providers & Services industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 49.75B, representing a year-over-year increase of 9.47%, while its net profit experienced a year-over-year increase of 30.86%.
Score
Financials
5.28
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
4.52
Operational Efficiency
4.70
Growth Potential
4.00
Shareholder Returns
5.71
Elevance Health Inc's Company Valuation
Currency: USD Updated: 2026-03-24The current valuation score of Elevance Health Inc is 6.88, ranking 40 out of 75 in the Healthcare Providers & Services industry. Its current P/E ratio is 11.49, which is 78.92% below the recent high of 20.55 and 3.30% above the recent low of 11.11.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 30/75
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-03-24The current earnings forecast score of Elevance Health Inc is 7.42, ranking 39 out of 75 in the Healthcare Providers & Services industry. The average price target is 395.00, with a high of 491.45 and a low of 297.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
24
analysts
Buy
Current Rating
385.021
Target Price
+32.09%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
9
Total
22
Median
19
Average
Company name
Ratings
Analysts
Elevance Health Inc
ELV
24
Unitedhealth Group Inc
UNH
30
Humana Inc
HUM
29
Cigna Group
CI
26
Centene Corp
CNC
22
Molina Healthcare Inc
MOH
20
1
2
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-03-24The current price momentum score of Elevance Health Inc is 6.88, ranking 25 out of 75 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 327.67 and the support level at 263.92, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
291.430
Sell
MA10
291.428
Sell
MA20
294.846
Sell
MA50
327.811
Sell
MA100
332.491
Sell
MA200
331.069
Sell
Institutional Confidence
Currency: USD Updated: 2026-03-24The current institutional shareholding score of Elevance Health Inc is 10.00, ranking 1 out of 75 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 97.95%, representing a quarter-over-quarter increase of 0.93%. The largest institutional shareholder is The Vanguard, holding a total of 22.90M shares, representing 10.38% of shares outstanding, with 6.55% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)
Wellington Management Company, LLP
Sanders Capital, LLC
Geode Capital Management, L.L.C.
Artisan Partners Limited Partnership
1
2
Risk Assessment
Currency: USD Updated: 2026-03-24The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Elevance Health Inc is 8.65, ranking 7 out of 75 in the Healthcare Providers & Services industry. The company's beta value is 0.50. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
0.50
VaR
+2.63%
240-Day Maximum Drawdown
+37.74%
240-Day Volatility
+38.36%
Return
Best Daily Return
60 days
+5.86%
120 days
+5.86%
5 years
+7.70%
Worst Daily Return
60 days
-14.33%
120 days
-14.33%
5 years
-14.33%
Sharpe Ratio
60 days
-1.36
120 days
-0.34
5 years
-0.02
Risk Assessment
Maximum Drawdown
240 days
+37.74%
3 years
+51.15%
5 years
+51.15%
Return-to-Drawdown Ratio
240 days
-0.86
3 years
-0.24
5 years
-0.10
Skewness
240 days
-1.91
3 years
-1.76
5 years
-1.32
Volatility
Realised Volatility
240 days
+38.36%
5 years
+30.95%
Standardised True Range
240 days
+3.70%
5 years
+3.64%
Downside Risk-Adjusted Return
120 days
-38.05%
240 days
-38.05%
Maximum Daily Upside Volatility
60 days
+28.01%
Maximum Daily Downside Volatility
60 days
+37.78%
Liquidity
Average Turnover Rate
60 days
+1.06%
120 days
+0.93%
5 years
--
Turnover Deviation
20 days
+57.20%
60 days
+64.18%
120 days
+45.36%
Peer Comparison
Healthcare Providers & Services
Elevance Health Inc
ELV
6.97 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
8.26 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Pediatrix Medical Group Inc
MD
8.21 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Natera Inc
NTRA
8.09 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Ensign Group Inc
ENSG
8.09 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cigna Group
CI
8.07 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
